arrhythmia and heart failure
Conditions
Interventions
Sponsors
the First Affiliated Hospital of Wenzhou Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. patients with cardiac pacing indications; 2. signing the informed consent of the patient and indicating the date of signing; 3. patients with relatively stable residential location; 4. patients were at least 18 years old and not pregnant at least 1 year; 5. life expectancy is more than 1 years.;Inclusion criteria: 1. patients with cardiac pacing indications; 2. signing the informed consent of the patient and indicating the date of signing; 3. patients with relatively stable residential location; 4. patients were at least 18 years old and not pregnant at least 1 year; 5. life expectancy is more than 1 years.;Inclusion criteria: 1. patients with cardiac pacing indications; 2. signing the informed consent of the patient and indicating the date of signing; 3. patients with relatively stable residential location; 4. patients were at least 18 years old and not pregnant at least 1 year; 5. life expectancy is more than 1 years.;Inclusion criteria: 1. patients with cardiac pacing indications; 2. signing the informed consent of the patient and indicating the date of signing; 3. patients with relatively stable residential location; 4. patients were at least 18 years old and not pregnant at least 1 year; 5. life expectancy is more than 1 years.;Inclusion criteria: 1. patients with cardiac pacing indications; 2. signing the informed consent of the patient and indicating the date of signing; 3. patients with relatively stable residential location; 4. patients were at least 18 years old and not pregnant at least 1 year; 5. life expectancy is more than 1 years.
Exclusion criteria
Exclusion criteria: 1. patients with expected life expectancy less than 12 months, and 2. patients with heart valve diseaseright or ventricular mechanical valve; 3. heart transplant patients or patients waiting for heart transplantation; 4. patients have been registered other clinical studies which may affect the purpose of this study. ;Exclusion criteria: 1. patients with expected life expectancy less than 12 months, and 2. patients with heart valve diseaseright or ventricular mechanical valve; 3. heart transplant patients or patients waiting for heart transplantation; 4. patients have been registered other clinical studies which may affect the purpose of this study. ;Exclusion criteria: 1. patients with expected life expectancy less than 12 months, and 2. patients with heart valve diseaseright or ventricular mechanical valve; 3. heart transplant patients or patients waiting for heart transplantation; 4. patients have been registered other clinical studies which may affect the purpose of this study. ;Exclusion criteria: 1. patients with expected life expectancy less than 12 months, and 2. patients with heart valve diseaseright or ventricular mechanical valve; 3. heart transplant patients or patients waiting for heart transplantation; 4. patients have been registered other clinical studies which may affect the purpose of this study. ;Exclusion criteria: 1. patients with expected life expectancy less than 12 months, and 2. patients with heart valve diseaseright or ventricular mechanical valve; 3. heart transplant patients or patients waiting for heart transplantation; 4. patients have been registered other clinical studies which may affect the purpose of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Paced morphology;Pacing parameters;success rate;clinical outcome; | — |
Countries
China
Contacts
Public ContactWeijian Huang;Weijian Huang;Weijian Huang;Weijian Huang;Weijian Huang ;;;;
the First Affiliated Hospital of Wenzhou Medical University;the First Affiliated Hospital of Wenzhou Medical University;the First Affiliated Hospital of Wenzhou Medical University;the First Affiliated Hospital of Wenzhou Medical University;the First Affiliated Hospital of Wenzhou Medical University
Outcome results
None listed